@article {1405,
	title = {Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals.},
	journal = {Clinical pharmacokinetics},
	volume = {44},
	year = {2005},
	month = {2005},
	pages = {99-109},
	abstract = {Delavirdine is a non-nucleoside reverse transcriptase inhibitor used in combination regimens for the treatment of HIV-1 infection. Our objective was to characterise the population pharmacokinetics of delavirdine in HIV-infected patients who participated in the adult AIDS Clinical Trials Group (ACTG) 260 and 261 studies.},
	keywords = {Adolescent, Adult, Anti-HIV Agents, Body Weight, Carbamazepine, Continental Population Groups, Delavirdine, Double-Blind Method, Drug Therapy, Combination, Female, HIV Infections, Humans, Male, Metabolic Clearance Rate, Middle Aged, Sex Factors},
	issn = {0312-5963},
	doi = {10.3109/00952990.2011.568081},
	author = {Smith, Patrick F and Dicenzo, Robert and Forrest, Alan and Shelton, Mark and Friedland, Gerald and Para, Michael and Pollard, Richard and Fischl, Margaret and DiFrancesco, Robin and Morse, Gene D}
}
